ARENA PHARMACEUTICALS INC 4

4 · ARENA PHARMACEUTICALS INC · Filed Apr 1, 2015

Form 4

Period: 2015-03-30

Director

Transactions

Exercise/Conversion
Common Stock
2015-03-30$1.27/sh+36,000$45,720→ 121,380 total
Exercise/Conversion
Stock Option (right to buy)
2015-03-30−40,268→ 12,000 total
Exercise: $1.49Exp: 2021-03-15→ Common Stock (40,268 underlying)
Exercise/Conversion
Common Stock
2015-03-30$1.49/sh+40,268$59,999→ 85,380 total
Sale
Common Stock
2015-03-30$4.49/sh−76,268$342,253→ 45,112 total
Exercise/Conversion
Stock Option (right to buy)
2015-03-30−36,000→ 0 total
Exercise: $1.27Exp: 2021-06-13→ Common Stock (36,000 underlying)

Footnotes (3)

[F1]The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $4.48 and $4.50 per share, inclusive. The reporting person undertakes to provide Arena Pharmaceuticals, Inc., any security holder of Arena Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
[F2]The options vested in 12 equal monthly installments over one year beginning on April 15, 2011, and became exercisable once vested.
[F3]The options vested in 12 equal monthly installments over one year beginning on July 13, 2011, and became exercisable once vested.

Documents

1 file